Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363166 · ClinicalTrials.gov registry record
Analysis of CA-MRSA Transmission: An ED Population Sampling Strategy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 575
- Enrollment target
NCT02363166: Completed study, sponsored by University of Florida.
NCT02363166 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 575 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02363166 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 575 participants
- Enrollment target
Study Summary
Given that the Emergency Department (ED) has become the entry way for large populations of patients into the health care system, a strategy of sampling MRSA isolates in ED populations and merging this information with patient-level data may present a window to hypothesize and investigate CA-MRSA transmission within the community and its impact on hospital-acquired infections.
Primary Outcome
Molecular (spa-typing) and genomic (WGS) relatedness of MRSA strains in isolates in ED populations presenting with SSTIs.
Interventions
- OTHER Acute Abscess Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 575 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-04-04 |
What the finished NCT02363166 record still lists
NCT02363166 is an observational study that tracks outcomes without assigning an intervention. The registered 575 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Acute Abscess Group is the first listed.
NCT02363166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02363166 about?
NCT02363166 is a clinical study titled "Analysis of CA-MRSA Transmission: An ED Population Sampling Strategy". Given that the Emergency Department (ED) has become the entry way for large populations of patients into the health care system, a strategy of sampling MRSA isolates in ED populations and merging this information with patient-level data may present a window to hypothesize and investigate CA-MRSA tra...
What is the current status of trial NCT02363166?
This trial is currently completed. The enrollment target is 575 participants. The study started on 2015-08. Estimated completion is 2018-04-04.
What interventions are being tested in trial NCT02363166?
The interventions under investigation include: Acute Abscess Group (OTHER).
Who is sponsoring clinical trial NCT02363166?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06583148 · 575 participants · NA
A Smoke-Free Home Intervention in Tribal Communities
- NCT06883175 · 575 participants · NA
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia